Pharmacomechanical coupling in vascular smooth muscle cells-an overview.
スポンサーリンク
概要
- 論文の詳細を見る
In vascular smooth muscles, neurotransmitters or autacoids produce contraction through activation of Ca<SUP>2+</SUP>-influx and release of Ca<SUP>2+</SUP> from intracellular store sites. These agonists appear to activate Ca<SUP>2+</SUP>-influxes in both voltage-dependent and voltage-independent manners. The release of Ca<SUP>2+</SUP> is thought to be linked to the action of inositol 1, 4, 5-trisphosphate. The phosphorylation of myosin light chain may be the mechanism for the Ca<SUP>2+</SUP>-induced contraction in smooth muscles. Some agonists only transiently increase cellular Ca<SUP>2+</SUP> and the phosphorylation of myosin, but they produce a sustained contraction in various vascular tissues. Hence, additional high Ca<SUP>2+</SUP>-sensitive mechanisms are no doubt involved in the contraction of vascular smooth muscle. In the present article, attention will be directed to the mechanisms and agonist-induced contraction in arterial smooth muscle.
- 公益社団法人 日本薬理学会の論文
著者
-
Itoh Takeo
Department Of Cellular And Molecular Pharmacology Graduate School Of Medical Sciences Nagoya City Un
-
Itoh Takeo
Department of Pharmacology, Faculty of Medicine,Kyusyu University
関連論文
- Overexpression of Myosin Phosphatase Reduces Ca2+ Sensitivity of Contraction and Impairs Cardiac Function
- Imidaprilat Potentiates Endothelium Dependent Hyperpolarizationin Rabbit Resistant Mesenteric Artery
- Overexpression of Myosin Phosphatase Reduces Ca^ Sensitivity of Contraction and Impairs Cardiac Function
- Pharmacomechanical coupling in vascular smooth muscle cells-an overview.
- Actions of a newly synthesized nitro-compound, E-4701, on rabbit vascular smooth muscles.